🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effect of macitentan at steady...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2020-01-14
Trial ID
NCT04211272
Treatments Being Tested
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
A surveillance of respiratory tract related adverse events in patients trea...
Status
Completed
Location
Cardiovascular Associates, P.C.
Start Date
2010-12
Trial ID
NCT01266265
This is a prospective, single-center, open-label, 3+3 dose escalation Phase...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2015-01-08
Trial ID
NCT02254954
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of macitentan o...
Status
Completed
Location
SGS Belgium NV
Start Date
2022-06-22
Trial ID
NCT05433675
Treatments Being Tested
The purpose of the study is to evaluate the change from baseline to 12 mont...
Status
Completed
Location
Generale Regionale F. Miulli
Start Date
2020-10-06
Trial ID
NCT04567602
Treatments Being Tested
The study evaluates the effect of macitentan on right ventricular and hemod...
Status
Completed
Location
Massachussetts General Hospital
Start Date
2015-06-01
Trial ID
NCT02310672
Treatments Being Tested
The aim of this open-label (OL) trial is to study the long-term use of maci...
Status
Terminated
Location
Massachusetts General Hospital Heart Center
Start Date
2019-04-11
Trial ID
NCT03775421
Treatments Being Tested
The endothelin receptor antagonist macitentan showed significant improvemen...
Status
Terminated
Location
Fukuoka University Nishijin Hospital
Start Date
2019-01-08
Trial ID
NCT03809650
Treatments Being Tested
SYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psy...
Status
Completed
Location
Cardiovascular Associates of the Southeast, LLC
Start Date
2013-04-01
Trial ID
NCT01841762
Treatments Being Tested